Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franziska Büscheck

Showing results (11-20 of 118) with videos related to

Pageof 12
Sort By:
Clinical Epigenetics|October 24, 2019
Random forest-based modelling to detect biomarkers for prostate cancer progressionReka Toth, Heiko Schiffmann, Claudia Hube-Magg, et al.
Virchows Archiv : an International Journal of Pathology|December 8, 2019
High homogeneity of mismatch repair deficiency in advanced prostate cancerChristoph Fraune, Ronald Simon, Doris Höflmayer, et al.
Urologic Oncology|February 19, 2020
MMR deficiency in urothelial carcinoma of the bladder presents with temporal and spatial homogeneity throughout the tumor massChristoph Fraune, Ronald Simon, Claudia Hube-Magg, et al.
Oncotarget|February 21, 2020
Prevalence and clinical significance of VHL mutations and 3p25 deletions in renal tumor subtypesFranziska Büscheck, Christoph Fraune, Ronald Simon, et al.
International Journal of Cancer|October 12, 2020
Chromosome 5 harbors two independent deletion hotspots at 5q13 and 5q21 that characterize biologically different subsets of aggressive prostate cancerKatharina Möller, Martina Kluth, Malik Ahmed, et al.
Urologic Oncology|October 17, 2018
Aberrant expression of membranous carbonic anhydrase IX (CAIX) is associated with unfavorable disease course in papillary and clear cell renal cell carcinomaFranziska Büscheck, Christoph Fraune, Ronald Simon, et al.
World Journal of Urology|April 19, 2020
High level of EZH2 expression is linked to high density of CD8-positive T-lymphocytes and an aggressive phenotype in renal cell carcinomaTill Eichenauer, Luca Simmendinger, Christoph Fraune, et al.
BMC Cancer|March 3, 2019
Aberrant expression of the microtubule-associated protein tau is an independent prognostic feature in prostate cancerCornelia Schroeder, Jan Grell, Claudia Hube-Magg, et al.
Experimental and Molecular Pathology|May 28, 2018
Up regulation of the steroid hormone synthesis regulator HSD3B2 is linked to early PSA recurrence in prostate cancerEmily Neubauer, Morwari Latif, Jenny Krause, et al.
World Journal of Urology|May 4, 2020
A non-diploid DNA status is linked to poor prognosis in renal cell cancerFranziska Büscheck, Christoph Fraune, Martina Kluth, et al.
Pageof 12

Showing results (11-20 of 118) with videos related to

Sort By:
Pageof 12
Clinical Epigenetics|October 24, 2019
Random forest-based modelling to detect biomarkers for prostate cancer progressionReka Toth, Heiko Schiffmann, Claudia Hube-Magg, et al.
Virchows Archiv : an International Journal of Pathology|December 8, 2019
High homogeneity of mismatch repair deficiency in advanced prostate cancerChristoph Fraune, Ronald Simon, Doris Höflmayer, et al.
Urologic Oncology|February 19, 2020
MMR deficiency in urothelial carcinoma of the bladder presents with temporal and spatial homogeneity throughout the tumor massChristoph Fraune, Ronald Simon, Claudia Hube-Magg, et al.
Oncotarget|February 21, 2020
Prevalence and clinical significance of VHL mutations and 3p25 deletions in renal tumor subtypesFranziska Büscheck, Christoph Fraune, Ronald Simon, et al.
International Journal of Cancer|October 12, 2020
Chromosome 5 harbors two independent deletion hotspots at 5q13 and 5q21 that characterize biologically different subsets of aggressive prostate cancerKatharina Möller, Martina Kluth, Malik Ahmed, et al.
Urologic Oncology|October 17, 2018
Aberrant expression of membranous carbonic anhydrase IX (CAIX) is associated with unfavorable disease course in papillary and clear cell renal cell carcinomaFranziska Büscheck, Christoph Fraune, Ronald Simon, et al.
World Journal of Urology|April 19, 2020
High level of EZH2 expression is linked to high density of CD8-positive T-lymphocytes and an aggressive phenotype in renal cell carcinomaTill Eichenauer, Luca Simmendinger, Christoph Fraune, et al.
BMC Cancer|March 3, 2019
Aberrant expression of the microtubule-associated protein tau is an independent prognostic feature in prostate cancerCornelia Schroeder, Jan Grell, Claudia Hube-Magg, et al.
Experimental and Molecular Pathology|May 28, 2018
Up regulation of the steroid hormone synthesis regulator HSD3B2 is linked to early PSA recurrence in prostate cancerEmily Neubauer, Morwari Latif, Jenny Krause, et al.
World Journal of Urology|May 4, 2020
A non-diploid DNA status is linked to poor prognosis in renal cell cancerFranziska Büscheck, Christoph Fraune, Martina Kluth, et al.
Pageof 12